Comparison of efficacy of Nortriptyline with TENS on painful diabetic peripheral neuropathy

Comparison of efficacy of nortriptyline with Transcutaneous Electrical Nerve Stimulation (TENS) on painful peripheral neuropathy in patients with diabetes

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20180212038705N2

Enrollment

Registered

2018-06-26

Start date

2017-11-06

Completion date

Unknown

Last updated

2018-07-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Painful diabetic peripheral neuropathy. Type 2 diabetes mellitus with diabetic neuropathy, unspecified

Interventions

Intervention 1: Intervention group: Nortriptyline (25 to 75 mg). Intervention 2: Intervention group: TENS.

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Age more than 18 years Type 1 and 2 diabetes Definitive diagnosis of diabetic neuropathy

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Pain severity. Timepoint: Every week. Method of measurement: Visual analog scale (VAS).	—

Secondary

Measure	Time frame
Side effects. Timepoint: Every week. Method of measurement: Examination and patient history.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMehrnoosh Zakerkish

Ahvaz University of Medical Sciences

Zakerkish@yahoo.com+98 61 3374 3001

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026